BCR-ABL1INS35 is not uncommon in CML patients and is related to resistance and sensitivity to inhibitors in CML treatment - Response

Tai Sung Lee*, Wanlong Ma, Xi Zhang, Maher Albitar, Francis Giles, Jorge Cortes, Hagop Kantarjian

*Corresponding author for this work

Research output: Contribution to journalLetter

1 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalMolecular cancer therapeutics
Volume9
Issue number3
DOIs
Publication statusPublished - Mar 1 2010

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this